CETAMP, Unimore’s New Centre for Precision Medicine, is Established
The University of Modena and Reggio Emilia (Unimore) has established the new Centre for Advanced Technologies and Therapies for Precision Medicine – CETAMP, dedicated to the development and clinical translation of innovative diagnostic and therapeutic technologies.
CETAMP was presented today in Rome, at the Chamber of Deputies, as part of the event “HEAL Italia 2036 – From Medicine for All to Medicine for Each Individual: Towards a National Strategy for Predictive and Precision Medicine”, by Professor Massimo Dominici, Full Professor of Oncology at Unimore.
The establishment of CETAMP responds to the need to address the growing complexity of contemporary medicine in a structured, integrated and innovative way, with a focus on personalised approaches based on molecular, clinical and digital evidence. Precision medicine is now a strategic pillar of international biomedical research and a concrete opportunity for clinical and industrial innovation.
The Centre, which aims to serve as a centre of excellence and technology transfer hub, was proposed by Professors Massimo Dominici and Carlo Bortolotti, Associate Professor of Physical Chemistry. It builds on Unimore’s experience in the HEAL Italia PNRR project, of which the University is a founding member. The aim is to integrate expertise currently distributed across different Departments, creating a multidisciplinary hub capable of connecting research, advanced technologies and clinical application.
“The approval of CETAMP represents a strategic decision for our University,” said Unimore Rector Rita Cucchiara. “Precision medicine requires ever-greater integration between medicine, biology, chemistry, physics, engineering and data science. Unimore has significant expertise across all these fields, and the new Centre will enable us to bring these capabilities together within a common framework. Its approval is the first step: in the coming months, we will need to establish the Centre’s structure, develop its projects and ensure that it has full operational capacity.”
CETAMP will focus on three main areas: new diagnostic technologies for precision medicine; advanced medical and surgical therapies; and personalised approaches to rare and fibro-inflammatory diseases. The technologies involved will include genomics, biosensors and liquid biopsy, artificial intelligence, 3D models and bioprinting, cell and gene therapies, nanomedicine and advanced robotics.
“We do not simply want to create another organisational structure, but a place where the expertise that is already strong across Modena and Reggio Emilia can converge,” said Professor Massimo Dominici. “The challenge is to shorten the distance between scientific discovery and clinical application. To make the Centre operational, we will now need to bring together research groups and technological platforms, develop new projects, attract funding and partnerships, and turn innovation into new opportunities for patients.”
“Precision medicine increasingly depends on our ability to measure and interpret the biological complexity of each individual,” added Professor Carlo Bortolotti. “CETAMP will make it possible to integrate biosensors, genomics, nanotechnologies, imaging and artificial intelligence with biological and clinical expertise, transforming data and technologies into new tools for prediction, diagnosis and treatment selection.”
The Centre will bring together expertise from seven Unimore Departments, in collaboration with local healthcare organisations and in connection with the national HEAL Italia network. The operational phase will begin in the coming months, with the integration of research groups and technological platforms, the development of new projects, and the pursuit of funding and partnerships aimed at translating innovation into new diagnostic and therapeutic opportunities for patients.
Categorie: International - english, Notizie_eng
Articolo pubblicato da: Ufficio Stampa Unimore - ufficiostampa@unimore.it il 13/10/2026